Blocking the middle meningeal artery for migraine treatment
Part of Brain & nervous system clinical trials.
This study tests a procedure that blocks a specific artery in the lining of the brain to see if it can reduce migraine attacks. If you have frequent migraines that haven't improved with medication, this might be a new option worth discussing with your doctor.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 to 80 years old.
- A doctor has diagnosed you with migraine, with or without aura (visual or sensory warning signs).
- You have at least 4 migraine days per month.
- You have tried migraine medications (preventive or treatment) for at least 6 months.
- You have no other major health issues causing headaches, such as a neck problem, sinus infection, or a previous head injury.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows adults who undergo a procedure called middle meningeal artery embolization—a minimally invasive treatment that blocks blood flow to a specific artery thought to trigger migraines. The trial simply tracks your symptoms and quality of life before and after the procedure to understand how well it works.
This trial tests a procedure called bilateral middle meningeal artery embolization to see if it reduces chronic migraine symptoms in people who haven't found relief from other treatments. It's for those with frequent, disabling migraines that affect both sides of the head.
This trial tests whether giving a numbing medicine (lidocaine) into a small artery in the face (the external carotid artery) can help people with hard-to-treat chronic migraines or persistent face/skull pain. It is for those who haven't found relief from standard treatments.
This study tests a procedure called MMA embolization (blocking a small artery in the head) to see if it can reduce migraine attacks in people with chronic, hard-to-treat migraines.
This trial tests a minimally invasive procedure called middle meningeal artery embolization (using tiny particles to block a small artery) to treat chronic subdural hematoma, a condition where blood slowly builds up on the brain's surface. The goal is to help the body reabsorb the blood and prevent the need for repeated surgeries.
This study tracks patients who get a procedure called middle meningeal artery embolization (a treatment that blocks blood flow to the lining of the brain to help a chronic subdural hematoma heal). The goal is to see how well it works and how patients recover over time.
Hear when a new Migraine trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.